510(k) K201938

LZI Fentanyl II Enzyme Immunoassay by Lin-Zhi International, Inc. — Product Code DJG

K201938 is an FDA 510(k) premarket notification submitted by Lin-Zhi International, Inc. for the device "LZI Fentanyl II Enzyme Immunoassay". The FDA issued a decision of Substantially Equivalent on August 7, 2020. The device falls under product code DJG (Enzyme Immunoassay, Opiates), a Class II device regulated under 21 CFR 862.3650. Lin-Zhi International, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 7, 2020
Date Received
July 13, 2020
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Immunoassay, Opiates
Device Class
Class II
Regulation Number
862.3650
Review Panel
TX
Submission Type